Looming patent cliffs and shrivelling pipelines have pharma's big players looking for new business models that will allow them to increase their bottom lines.
Blog
Where our team of editors discuss what they think about the current NGP US Issues.
Editor NGP Europe
Latest News
GlaxoSmithKline defends anti-ageing drugs
Pharmaceutical giant GlaxoSmithKline has defended drugs, which it has financially backed, that...
read moreComments
Genzyme reports Q2 loss after inventory write-off
Genzyme, the US biotech firm that pharma giant Sanofi-Aventis is currently trying to purchase,...
read moreComments
Novartis Alcon deal approved by regulators
A deal that saw Swiss drugmaker Novartis buy a minority stake in Alcon has received approval from...
read moreComments
Shire profits increase for quarter
British drugmaker Shire, who is currently buying Belgian firm Movetis, has defied analysts’...
read moreComments
MorphoSys to receive Novartis milestone payout
German biotech company MorphoSys has announced that it is to receive a milestone payment from...
read moreComments
Sanofi-Aventis to takeover Genzyme?
Industry reports indicate that pharmaceutical giant Sanofi-Aventis has approached the board of...
read moreComments
Teva profits up 53 percent
Teva Pharmaceutical, the global leader in the makers of generic drugs, has stated that its Q2...
read moreComments
The growth of HTS (Hit-throughput screening)
Back in May, it was announced that new stem cell research would reduce the need for animal...
read moreComments
Actelion to buy Trophos
Trophos, a French clinical stage pharmaceutical company, has been optioned to Swiss...
read moreComments
Avandia GlaxoSmithKline face £1.5bn legal bill
The pharma giant is reportedly set to face a legal charge of £1.57 billion for the second quarter...
read moreComments
NGP Europe Summit: Drug Discovery
1st - 3rd September 2010
The Next Generation Drug Discovery Summit Europe is designed to bridge the growing technological gap between drug discovery and drug development.
Source: www.ngpharma.eu.com© 2010 GDS Publishing Ltd. All rights reserved.